EURODIN Side Effects

6961497-6 | Toxic Epidermal Necrolysis
on Aug 27, 2010 Male patient from JAPAN , 66 years of age, weighting 119.0 lb, was treated with Eurodin (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis. Eurodin dosage: . During the same period patient was treated with EVAMYL (View Evamyl Review and Evamyl Label ), SERENACE (View Serenace Review and Serenace Label ), TAGAMET (View Tagamet Review and Tagamet Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), OPALMON (View Opalmon Review and Opalmon Label ), LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LOXONIN (View Loxonin Review and Loxonin Label ). Patient was hospitalized.

6914399-5 | Toxic Epidermal Necrolysis
Patient was taking Eurodin (View Usage). Patient had the following side effects: toxic epidermal necrolysis on Jul 30, 2010 from JAPAN Additional patient health information: Male patient , 66 years of age, . Eurodin dosage: . During the same period patient was treated with EVAMYL (View Evamyl Review and Evamyl Label ), SERENACE (View Serenace Review and Serenace Label ), TAGAMET (View Tagamet Review and Tagamet Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), OPALMON (View Opalmon Review and Opalmon Label ), LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LOXONIN (View Loxonin Review and Loxonin Label ). Patient was hospitalized.

6736284-4 | Coma, Intentional Overdose
Adverse event was reported on May 12, 2010 by a Female patient taking Eurodin (View Usage) (Dosage: 40 Tablets) was diagnosed with insomnia and. Location: JAPAN , 83 years of age, After Eurodin was administered, patient had the following side effects: coma, intentional overdose. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ), LINBULANE (View Linbulane Review and Linbulane Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6701562-1 | Altered State Of Consciousness, Intentional Overdose
on Apr 20, 2010 Female patient from JAPAN , 83 years of age, was diagnosed with insomnia and was treated with Eurodin (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, intentional overdose. Eurodin dosage: . During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ), LINBULANE (View Linbulane Review and Linbulane Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.


6594775-3 | Agitation, Polydipsia, Water Intoxication
on Feb 12, 2010 Male patient from JAPAN , 36 years of age, was treated with Eurodin (View Usage). Patient had the following side effects: agitation, polydipsia, water intoxication. Eurodin dosage: . During the same period patient was treated with HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), LEVOMEPROMAZINE MALEATE (View Levomepromazine Maleate Review and Levomepromazine Maleate Label ), ZOTEPINE (View Zotepine Review and Zotepine Label ).

6033106-4 | Cerebral Infarction, Colon Cancer, Gastrointestinal Haemorrhage
Patient was taking Eurodin (View Usage). After Eurodin was administered, patient had the following side effects: cerebral infarction, colon cancer, gastrointestinal haemorrhage on Jan 06, 2009 from JAPAN Additional patient health information: Female patient , 85 years of age, was diagnosed with insomnia, cardiac failure chronic, colon cancer, arteriosclerosis obliterans, hypertension and. Eurodin dosage: . During the same period patient was treated with BLOPRESS (View Blopress Review and Blopress Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), DIART (View Diart Review and Diart Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), NORVASC (View Norvasc Review and Norvasc Label ).

5918991-6 | Hepatitis Acute
Adverse event was reported on Oct 10, 2008 by a Female patient taking Eurodin (View Usage) (Dosage: ) was diagnosed with insomnia and. Location: JAPAN , 64 years of age, Patient experienced the following unwanted or unexpected effects: hepatitis acute. During the same period patient was treated with LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ). Patient was hospitalized.

5767572-6 | Suicide Attempt
on Jun 05, 2008 Female patient from JAPAN , 75 years of age, was treated with Eurodin (View Usage). Patient had the following side effects: suicide attempt. Eurodin dosage: . During the same period patient was treated with FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ). Patient was hospitalized.

5723884-3 | Loss Of Consciousness, Overdose, Pneumonia Aspiration
on Apr 23, 2008 Female patient from JAPAN , 77 years of age, was treated with Eurodin (View Usage). After Eurodin was administered, patient had the following side effects: loss of consciousness, overdose, pneumonia aspiration. Eurodin dosage: . Patient was hospitalized.

5163997-0 | Blood Cholesterol Decreased, Pulmonary Embolism
Patient was taking Eurodin (View Usage). Patient experienced the following unwanted or unexpected effects: blood cholesterol decreased, pulmonary embolism (What is pulmonary embolism?) on Sep 01, 2006 from JAPAN Additional patient health information: Male patient , weighting 134.9 lb, was diagnosed with insomnia, alcoholic psychosis and. Eurodin dosage: . During the same period patient was treated with VEGETAMIN (View Vegetamin Review and Vegetamin Label ), LODOPIN (View Lodopin Review and Lodopin Label ), LULLAN (View Lullan Review and Lullan Label ), ETHYL LOFLAZEPATE (View Ethyl Loflazepate Review and Ethyl Loflazepate Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

5153572-6 | Blood Cholesterol Decreased, Pulmonary Embolism
Adverse event was reported on Sep 01, 2006 by a Male patient taking Eurodin (View Usage) (Dosage: ) was diagnosed with insomnia, alcoholic psychosis and. Location: JAPAN , weighting 134.9 lb, Patient had the following side effects: blood cholesterol decreased, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with VEGETAMIN (View Vegetamin Review and Vegetamin Label ), LODOPIN (View Lodopin Review and Lodopin Label ), LULLAN (View Lullan Review and Lullan Label ), ETHYL LOFLAZEPATE (View Ethyl Loflazepate Review and Ethyl Loflazepate Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

5151083-5 | Blood Cholesterol Decreased, Pulmonary Embolism
on Sep 01, 2006 Male patient from JAPAN , weighting 134.9 lb, was diagnosed with insomnia, alcoholic psychosis and was treated with Eurodin (View Usage). After Eurodin was administered, patient had the following side effects: blood cholesterol decreased, pulmonary embolism (What is pulmonary embolism?). Eurodin dosage: . During the same period patient was treated with VEGETAMIN (View Vegetamin Review and Vegetamin Label ), LODOPIN (View Lodopin Review and Lodopin Label ), LULLAN (View Lullan Review and Lullan Label ), ETHYL LOFLAZEPATE (View Ethyl Loflazepate Review and Ethyl Loflazepate Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

5151063-X | Anaemia, Blood Cholesterol Decreased, Condition Aggravated, Dehydration, Incorrect Dose Administered, Malnutrition, Pelvic Venous Thrombosis, Pulmonary Embolism, Pulmonary Hypertension
on Sep 01, 2006 Male patient from JAPAN , weighting 134.9 lb, was diagnosed with insomnia, alcoholic psychosis and was treated with Eurodin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, blood cholesterol decreased, condition aggravated, dehydration, incorrect dose administered, malnutrition, pelvic venous thrombosis, pulmonary embolism (What is pulmonary embolism?), pulmonary hypertension (What is pulmonary hypertension?). Eurodin dosage: . During the same period patient was treated with VEGETAMIN (View Vegetamin Review and Vegetamin Label ), LODOPIN (View Lodopin Review and Lodopin Label ), LULLAN (View Lullan Review and Lullan Label ), ETHYL LOFLAZEPATE (View Ethyl Loflazepate Review and Ethyl Loflazepate Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

5150958-0 | Blood Cholesterol Decreased, Pulmonary Embolism
Patient was taking Eurodin (View Usage). Patient had the following side effects: blood cholesterol decreased, pulmonary embolism (What is pulmonary embolism?) on Nov 02, 2006 from JAPAN Additional patient health information: Male patient , weighting 134.9 lb, was diagnosed with insomnia, alcoholic psychosis and. Eurodin dosage: . During the same period patient was treated with VEGETAMIN (View Vegetamin Review and Vegetamin Label ), LODOPIN (View Lodopin Review and Lodopin Label ), LULLAN (View Lullan Review and Lullan Label ), ETHYL LOFLAZEPATE (View Ethyl Loflazepate Review and Ethyl Loflazepate Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

5150958-0 | Blood Cholesterol Decreased, Pulmonary Embolism
Adverse event was reported on Sep 01, 2006 by a Male patient taking Eurodin (View Usage) (Dosage: ) was diagnosed with insomnia, alcoholic psychosis and. Location: JAPAN , weighting 134.9 lb, After Eurodin was administered, patient had the following side effects: blood cholesterol decreased, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with VEGETAMIN (View Vegetamin Review and Vegetamin Label ), LODOPIN (View Lodopin Review and Lodopin Label ), LULLAN (View Lullan Review and Lullan Label ), ETHYL LOFLAZEPATE (View Ethyl Loflazepate Review and Ethyl Loflazepate Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

5150677-0 | Blood Cholesterol Decreased, Pulmonary Embolism
on Sep 01, 2006 Male patient from JAPAN , weighting 134.9 lb, was diagnosed with insomnia, alcoholic psychosis and was treated with Eurodin (View Usage). Patient experienced the following unwanted or unexpected effects: blood cholesterol decreased, pulmonary embolism (What is pulmonary embolism?). Eurodin dosage: . During the same period patient was treated with VEGETAMIN (View Vegetamin Review and Vegetamin Label ), LODOPIN (View Lodopin Review and Lodopin Label ), LULLAN (View Lullan Review and Lullan Label ), ETHYL LOFLAZEPATE (View Ethyl Loflazepate Review and Ethyl Loflazepate Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

5136138-3 | Neuroleptic Malignant Syndrome
on Oct 06, 2006 Male patient from JAPAN , 38 years of age, weighting 160.9 lb, was treated with Eurodin (View Usage). Patient had the following side effects: neuroleptic malignant syndrome. Eurodin dosage: . During the same period patient was treated with LEVOMEPROMAZINE (View Levomepromazine Review and Levomepromazine Label ), PROMETHAZINE HCL (View Promethazine Hcl Review and Promethazine Hcl Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), CLOXAZOLAM (View Cloxazolam Review and Cloxazolam Label ), NITRAZEPAM (View Nitrazepam Review and Nitrazepam Label ). Patient was hospitalized.

5127908-6 | Neuroleptic Malignant Syndrome
Patient was taking Eurodin (View Usage). After Eurodin was administered, patient had the following side effects: neuroleptic malignant syndrome on Oct 06, 2006 from JAPAN Additional patient health information: Male patient , 38 years of age, weighting 160.9 lb, . Eurodin dosage: . During the same period patient was treated with LEVOMEPROMAZINE (View Levomepromazine Review and Levomepromazine Label ), PROMETHAZINE HCL (View Promethazine Hcl Review and Promethazine Hcl Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), CLOXAZOLAM (View Cloxazolam Review and Cloxazolam Label ), NITRAZEPAM (View Nitrazepam Review and Nitrazepam Label ). Patient was hospitalized.

5117137-4 | Blood Cholesterol Decreased, Pulmonary Embolism
Adverse event was reported on Sep 01, 2006 by a Male patient taking Eurodin (View Usage) (Dosage: ) was diagnosed with insomnia and. Location: JAPAN , 52 years of age, weighting 134.9 lb, Patient experienced the following unwanted or unexpected effects: blood cholesterol decreased, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with PROMETHAZINE HCL (View Promethazine Hcl Review and Promethazine Hcl Label ), ZOTEPINE (View Zotepine Review and Zotepine Label ), CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), PEROSPIRONE HYDROCHLORIDE (View Perospirone Hydrochloride Review and Perospirone Hydrochloride Label ), ETHYL LOFLAZEPATE (View Ethyl Loflazepate Review and Ethyl Loflazepate Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ). Patient was hospitalized.

5106013-9 | Anaemia, Blood Cholesterol Decreased, Cardiomegaly, Condition Aggravated, Pulmonary Embolism, Pulmonary Hypertension, Right Ventricular Failure, Tricuspid Valve Incompetence
on Sep 01, 2006 Male patient from JAPAN , 52 years of age, weighting 134.9 lb, was diagnosed with insomnia and was treated with Eurodin (View Usage). Patient had the following side effects: anaemia, blood cholesterol decreased, cardiomegaly, condition aggravated, pulmonary embolism (What is pulmonary embolism?), pulmonary hypertension (What is pulmonary hypertension?), right ventricular failure, tricuspid valve incompetence. Eurodin dosage: . During the same period patient was treated with PROMETHAZINE HCL (View Promethazine Hcl Review and Promethazine Hcl Label ), ZOTEPINE (View Zotepine Review and Zotepine Label ), CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), PEROSPIRONE HYDROCHLORIDE (View Perospirone Hydrochloride Review and Perospirone Hydrochloride Label ), ETHYL LOFLAZEPATE (View Ethyl Loflazepate Review and Ethyl Loflazepate Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ). Patient was hospitalized.

5102171-0 | Pulmonary Embolism
on Sep 01, 2006 Male patient from JAPAN , 52 years of age, weighting 134.9 lb, was diagnosed with insomnia and was treated with Eurodin (View Usage). After Eurodin was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Eurodin dosage: . During the same period patient was treated with PROMETHAZINE HCL (View Promethazine Hcl Review and Promethazine Hcl Label ), ZOTEPINE (View Zotepine Review and Zotepine Label ), CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), PEROSPIRONE HYDROCHLORIDE (View Perospirone Hydrochloride Review and Perospirone Hydrochloride Label ), ETHYL LOFLAZEPATE (View Ethyl Loflazepate Review and Ethyl Loflazepate Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ). Patient was hospitalized.

4980079-9 | Eosinophil Count Increased, Neutrophil Count Decreased
Patient was taking Eurodin (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophil count increased, neutrophil count decreased on Apr 03, 2006 from JAPAN Additional patient health information: Female patient , weighting 8.82 lb, was diagnosed with hypertonia, congenital intestinal malformation, sepsis (What is sepsis?), catheter related infection, nystagmus, periventricular leukomalacia and. Eurodin dosage: . During the same period patient was treated with LAC B (View Lac-b Review and Lac-b Label ), PRIMAXIN (View Primaxin Review and Primaxin Label ), HABEKACIN (View Habekacin Review and Habekacin Label ), ZONISAMIDE (View Zonisamide Review and Zonisamide Label ), CERCINE (View Cercine Review and Cercine Label ), ONEALFA (View Onealfa Review and Onealfa Label ). Patient was hospitalized.

4638205-7 | Hepatotoxicity
Adverse event was reported on Apr 08, 2005 by a Male patient taking Eurodin (View Usage) (Dosage: ) . Location: , 57 years of age, Patient had the following side effects: hepatotoxicity.

4596958-0 | Cerebral Haemorrhage, Difficulty In Walking, Fall, Hypotonia, Overdose
on Feb 04, 2005 Female patient from , 88 years of age, was diagnosed with sleep disorder (What is sleep disorder?) and was treated with Eurodin (View Usage). After Eurodin was administered, patient had the following side effects: cerebral haemorrhage, difficulty in walking, fall (What is fall?), hypotonia, overdose. Eurodin dosage: . Patient was hospitalized.

4582461-0 | Difficulty In Walking, Fall, Hypotonia, Overdose
on Feb 04, 2005 Female patient from , 88 years of age, was diagnosed with sleep disorder (What is sleep disorder?) and was treated with Eurodin (View Usage). Patient experienced the following unwanted or unexpected effects: difficulty in walking, fall (What is fall?), hypotonia, overdose. Eurodin dosage: . Patient was hospitalized.